Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.

A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin / M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - 9:2(2021 Feb), pp. 978-982. [10.1002/ccr3.3717]

A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

F. Serpenti
Secondo
;
G.A. Croci;A. Esposito;G.N. Saporiti;L. Baldini;F. Onida
Penultimo
;
2021-02

Abstract

Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
bulky lymphadenopathy; midostaurin; purine analogue; systemic mastocytosis;
Settore MED/08 - Anatomia Patologica
29-dic-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Clinical Case Reports - 2021 - Scium - A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 703.14 kB
Formato Adobe PDF
703.14 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/905921
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact